| Literature DB >> 27079327 |
Eun-Jeong Joo1, Joon-Sup Yeom1, Young Eun Ha2, So Yeon Park3, Chong-Suh Lee4, Eun-Sang Kim5, Cheol-In Kang2, Doo-Ryeon Chung2, Jae-Hoon Song2, Kyong Ran Peck2.
Abstract
BACKGROUND/AIMS: This study aimed to evaluate the efficacy of computed tomography (CT)-guided bone biopsy for the diagnosis of spinal infection and compared the clinical outcomes between tuberculous and pyogenic spinal infections.Entities:
Keywords: Biopsy; Computed tomography; Percutaneous; Spondylitis; Tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 27079327 PMCID: PMC4939487 DOI: 10.3904/kjim.2013.019
Source DB: PubMed Journal: Korean J Intern Med ISSN: 1226-3303 Impact factor: 2.884
Microbiologic and pathologic yield of computed tomography-guided bone biopsy
| Infectious spondylitis | Total no. (%) (n = 100) | No. of cases (%) | |
|---|---|---|---|
| Pyogenic spondylitis (n = 67) | Tuberculous spondylitis (n = 33) | ||
| Definite and probable cases | 58 (58) | 36 (54) | 22 (67) |
| Proven by bone tissue obtained from CT-guided bone biopsy | 42 (42) | 22 (33) | 20 (61) |
| Proven by other tissues not obtained from CT-guided biopsy | 16 (16) | 14 (21) | 2 (6) |
CT, computed tomography.
Clinical characteristics in groups of pyogenic and tuberculous spondylitis
| Variable | No. of cases (%) | |||
|---|---|---|---|---|
| Total (n = 100) | Pyogenic spondylitis (n = 67) | Tuberculous spondylitis (n = 33) | ||
| Age, yr | 56 (43–64) | 57 (42–66) | 54 (44–4) | 0.892 |
| Male sex | 61 (61) | 46 (68.7) | 15 (45.5) | 0.044 |
| Fever | 46 (46) | 35 (52.2) | 11 (33.3) | 0.038 |
| Underlying disease | ||||
| Diabetes | 13 (13) | 7 (10.4) | 6 (18.2) | 0.360 |
| Hypertension | 13 (13) | 6 (9.0) | 7 (21.2) | 0.127 |
| Renal insufficiency | 6 (6) | 2 (3.0) | 4 (12.1) | 0.177 |
| Chronic liver disease | 4 (4) | 3 (4.5) | 1 (3.0) | 1.000 |
| Spinal disease | 26 (26) | 23 (34.3) | 3 (9.1) | 0.004 |
| Others | 25 (25) | 15 (22.4) | 10 (30.3) | 0.491 |
| Involved spines | 0.002 | |||
| Cervical thoracolumbar | 29 (29) | 12 (17.9) | 17 (51.5) | |
| Cervical | 1 (1) | 0 | 1 (3.0) | |
| Thoracic | 19 (19) | 8 (11.9) | 11 (33.3) | |
| Thoracolumbar | 9 (9) | 4 (6.0) | 5 (15.2) | |
| Lumbar-sacral | 69 (69) | 53 (79.1) | 16 (48.5) | |
| Lumbar | 56 (56) | 41 (61.2) | 15 (45.5) | |
| Lumbosacral | 13 (13) | 12 (17.9) | 1 (3.0) | |
| Extensive | 2 (2) | 2 (3.0) | 0 | |
| Presence of abscess[ | 49 (49) | 30 (44.8) | 19 (57.6) | 0.229 |
| Index of inflammation | ||||
| WBC, × 1,000 cells/µL | 7,760 (6,300–10,020) | 8,050 (6,712–10,140) | 6,800 (5,670–9,075) | 0.016 |
| ESR, mm/hr | 58.00 (28.00–79.00) | 64.50 (42.25–88.50) | 52.00 (22.00–70.50) | 0.038 |
| CRP, mg/dL | 3.43 (0.97–7.61) | 4.07 (1.64–9.05) | 2.55 (0.71–5.01) | 0.179 |
| Surgical intervention | 46 (46) | 30 (44.8) | 16 (48.5) | |
| Early (within 1 month) | 30 (30) | 23 (76.7) | 7 (43.8) | |
| Late (after 1 month) | 16 (16) | 7 (23.3) | 9 (56.3) | 0.026 |
| 30-Day mortality | 3 (3) | 2 (3.0) | 1 (3.0) | |
| Repetitive surgery | 1 (1) | 0 | 1 (3.0) | |
| Unknown, follow-up loss | 12 (12) | 7 (10.4) | 5 (15.2) | |
| Hospital stay | 32 (19–50) | 38 (24–52) | 21 (9–35) | 0.003 |
Values are presented as median (interquartile range) or number (%). Characteristics of groups between pyogenic and tuberculous spondylitis were compared in the analysis including definite, probable, and possible cases.
WBC, white blood cell count; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
Abscess at psoas muscles, epidural space, and paravertebral area.
Isolated organisms
| Isolated organism | No. of isolates (%) (n = 38) |
|---|---|
| Gram-positive organisms | 26 (68.4) |
| | 21 (55.3) |
| | 18 (47.4) |
| Methicillin-susceptible[ | 17 (44.7) |
| Methicillin-resistant[ | 1 (2.6) |
| Coagulase-negative staphylococcus | 3 (7.9) |
| Methicillin-susceptible | 2 (5.3) |
| Methicillin-resistant | 1 (2.6) |
| | 2 (5.3) |
| | 2 (5.3) |
| Gram negative organisms | 8 (21.1) |
| | 2 (5.3) |
| | 2 (5.3) |
| | 1 (2.6) |
| | 1 (2.6) |
| | 1 (2.6) |
| | 1 (2.6) |
| Fungus | 4 (10.5) |
| | 3 (7.9) |
| | 1 (2.6) |
Mixed organisms with methicillin-susceptible S. aureus and Streptococcus viridans in one patient.
Mixed organisms with methicillin-resistant S. aureus and Enterococcus faecalis in one patient.
Clinical characteristics in patients with culture-positive and negative results in bacterial infection group
| Variable | No. of patients | ||
|---|---|---|---|
| Culture-positive (n = 32) | Culture-negative (n = 31) | ||
| Age, yr | 57 (42–69) | 55 (40–62) | 0.487 |
| Male sex | 23 (71.9) | 19 (61.3) | 0.373 |
| Underlying disease | 24 (75.0) | 18 (58.1) | 0.154 |
| Previous antibiotic-usage | 21 (65.6) | 14 (45.2) | 0.102 |
| Fever | 12 (37.5) | 13 (41.9) | 0.719 |
| Index of inflammation | 32 | 30 | |
| WBC, × 1,000 cells/µL | 8,290 (6,640–14,930) | 7,990 (6,700–9,360) | 0.011 |
| ESR, mm/hr | 66.5 (52.8–98.8) | 61.0 (31.8–84.8) | 0.075 |
| CRP, mg/dL | 6.95 (3.37–13.63) | 2.30 (0.68–4.24) | < 0.001 |
| Surgical intervention | 16 (50.0) | 11 (35.5) | 0.244 |
| Clinical improvement[ | 28 (87.5) | 27 (87.1) | 0.263 |
| Hospital stay | 42 (28–55) | 31 (35–50) | 0.064 |
Values are presented as median (interquartile range) or number (%). Characteristics between patients with definite and possible bacterial infections were compared. Four fungal cases were not introduced in this analysis.
WBC, white blood cell count; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
Assessment at at 4 weeks during the course of therapy.
Late surgical attempts in 16 patients
| No. | Age | Sex | Clinical diagnosis | Comorbidity | Time of surgery | Abscess | Reasons for late surgery | Level | Treatment regimen | Duration, mon |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 52 | F | Tuberculous, possible | Pulmonary TB | 72 | Yes | Delayed surgery | T6-8 | HREZ | 18 |
| 2 | 50 | F | Tuberculous, probable | No | 71 | Yes | Progression of abscess | L3-4 | HREZ | 17 |
| 3 | 73 | M | Tuberculous, possible | HTN | 54 | Yes | Progression of abscess | T10-11 | HREZ | 10 |
| 4 | 21 | M | Pyogenic, definite | No | 126 | No | Neurologic deficit | L4-5 | PIP/TAZ, CFTZ, SMX/TMP | 6 |
| 5 | 43 | M | Tuberculous, definite | Pulmonary TB | 38 | Yes | Progression of abscess | T10-12 | HREZ | 18 |
| 6 | 61 | F | Tuberculous, definite | Pulmonary TB | 56 | No | Delayed surgery | L2-3 | HREZ | 14 |
| 7 | 54 | M | Pyogenic, possible | HIVD | 48 | Yes | Aggravation of back pain | L4-5 | CFZ, CIP, CLND | 2.5 |
| 8 | 47 | F | Tuberculous, probable | Pulmonary TB | 55 | Yes | Delayed surgery | T12-L1 | HREZ | 15 |
| 9 | 54 | M | Pyogenic, definite | HIVD | 195 | Yes | Relapsed infection | L4-5 | Fluconazole | 2 |
| 10 | 44 | M | Tuberculous, probable | HIVD | 306 | No | Neurologic deficit | L2-3 | HREZ | 12 |
| 11 | 22 | F | Tuberculous, probable | Pulmonary TB | 50 | Yes | Progression of abscess | L1-2 | HREZ | 14 |
| 12 | 25 | M | Pyogenic, possible | HIVD | 67 | No | Neurologic deficit | L3-4 | CFZ→CIP, CLND | 2 |
| 13 | 60 | F | Pyogenic, possible | Behcet | 81 | Yes | Progression of abscess | L5 | CFZ→CIP, RFP | 12 |
| 14 | 78 | F | Pyogenic, possible | HTN | 59 | No | New abscess formation | L3-S | CTRX, VANC→LFLX, RFP | 4 |
| 15 | 69 | M | Pyogenic, definite | LC, CRF | 61 | Yes | Progression of abscess | T11-12 | MERO | 2.5 |
| 16 | 57 | F | Tuberculous, definite | HIVD | 102 | Yes | Delayed surgery | C6-T3 | HREZ | 15 |
TB, tuberculosis; HREZ, isoniazid + rifampicin + ethambutol + pyrazinamide; HTN, hypertension; PIP/TAZ, piperacillin/tazobactam; CFTZ, ceftazidime; SMX/TMP, sufamethoxazole/trimethoprim; HIVD, herniated intervertebral disc; CFZ, cefazolin; CIP, ciprofloxacin; CLND, clindamycin; RFP, rifampicin; CTRX, ceftriaxone; VANC, vancomycin; LFLX, levofloxacin; LC, liver cirrhosis; CRF, chronic renal failure; MERO, meropenem.